Inpatient Pain Management for Cancer Patients
The recommended approach for inpatient pain management in cancer patients involves systematic assessment of pain using standardized tools, followed by a stepwise analgesic therapy based on pain intensity, with regular reassessment and management of side effects. 1, 2
Pain Assessment
All cancer patients should be evaluated for pain at every clinical encounter using standardized self-reporting tools such as visual analog scales (VAS), numerical rating scales (NRS), or verbal rating scales (VRS) 1, 2
The key screening question should be: "What has been your worst pain in the last 24 hours on a scale of 0-10?" where 0 is no pain and 10 is the worst imaginable 1
Comprehensive assessment should include:
For patients with cognitive impairment, observe pain-related behaviors such as facial expressions, body movements, vocalizations, and changes in interactions 1
Pharmacological Management Based on Pain Intensity
Mild Pain (NRS 1-4)
- Non-opioid analgesics: acetaminophen/paracetamol (maximum 4000 mg/day) or NSAIDs 1, 2
- Provide gastroprotection when using NSAIDs long-term 3
Moderate Pain (NRS 5-7)
- Add weak opioids (codeine, dihydrocodeine, tramadol) to non-opioid analgesics 1, 2
- Alternatively, use low doses of strong opioids such as morphine or oxycodone 1
- Consider controlled-release formulations for stable pain 1
Severe Pain (NRS 8-10)
- Strong opioids: morphine (preferred first-line), hydromorphone, oxycodone, or fentanyl 2, 3
- For opioid-naïve patients, start with lower doses and titrate 1
- For opioid-tolerant patients:
- Calculate previous 24-hour total requirement
- For oral administration: administer 10-20% of total daily requirement
- For IV administration: convert to equivalent dose and administer 10-20% 1
Principles of Opioid Administration
- Provide around-the-clock dosing for persistent pain rather than "as needed" 1, 2
- Include breakthrough doses (typically 10-15% of total daily dose) for transient pain exacerbations 2, 3
- Titrate doses rapidly to achieve effective pain control 2
- For IV morphine, the usual starting dose in adults is 0.1 mg to 0.2 mg per kg every 4 hours as needed, administered slowly 4
- Adjust the baseline opioid regimen if more than four breakthrough doses are needed daily 2
- Convert to oral medications when feasible, including extended-release agents with rescue doses 1
Management of Opioid Side Effects
- Anticipate and proactively manage common side effects 2:
- Constipation: prophylactic laxatives
- Nausea/vomiting: antiemetics
- Central nervous system toxicity: dose reduction or opioid rotation
- Monitor patients with hepatic and renal impairment closely, starting with lower doses and titrating slowly 4
Adjuvant Analgesics
- For neuropathic pain, consider:
- For bone pain, consider bone-modifying agents (bisphosphonates, denosumab) 2, 3
Non-Pharmacological and Interventional Approaches
- Consider radiation therapy for localized bone pain 2, 3
- Consider surgical stabilization for impending fractures 2, 3
- For pain inadequately controlled despite optimal pharmacologic therapy, consider:
- Regional infusion of analgesics
- Nerve blocks
- Vertebral augmentation 2
Monitoring and Follow-up
- Assess pain during each contact or at least daily for inpatients 1
- Reassess both pain and analgesic side effects regularly 1
- Review analgesic regimen if side effects are present and/or pain persists 1
- Provide written follow-up pain plan, including prescribed medications 1
Common Pitfalls to Avoid
- Underestimating pain severity in patients with cognitive impairment 1
- Failing to recognize that most cancer patients have at least two types of cancer-related pain 1
- Inadequate titration of opioids leading to poor pain control 2
- Not addressing opiophobia in patients and families 1
- Neglecting to provide prophylactic management of opioid side effects 2
- Overlooking the psychosocial impact of pain on patients 1